CompletedNot Applicable

Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD

United States131 participantsStarted 2024-06-13

Plain-language summary

The primary objective of this study is to evaluate the ability of TOME to increase Medication for Opioid Use Disorder (MOUD) and opioid-overdose knowledge in pregnant and postpartum persons.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years of age or older;
✓. Pregnant or be within 12 months postpartum;
✓. Enrolled in MOUD (either buprenorphine or methadone) at the study site or affiliated clinic where enrollment can be confirmed;
✓. Able to understand the study, and having understood, provide written informed consent in English

What they're measuring

Medication for Opioid Use Disorder (MOUD) Knowledge Score

Timeframe: Week 3

Opioid Overdose Knowledge Score

Timeframe: Week 3

Trial details

NCT IDNCT06262347

SponsorT. John Winhusen, PhD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11-11

Results submitted2025-04-03

View on ClinicalTrials.gov More Opioid Use Disorder trials